UnityPoint Health Ventures

UnityPoint Health Ventures is the corporate venture capital arm of UnityPoint Health, one of the most integrated health systems in the United States, launched in 2019 and based in West Des Moines, Iowa. The firm runs a $100 million Innovation Fund that invests in early-stage growth companies across four areas: digital health, medical devices, therapeutic spaces and health care services, spanning digital therapeutics, health IT, tech-enabled services, medical devices and diagnostics, while deliberately steering clear of pharma, biopharma and drug discovery. It concentrates on seed, Series A and Series B rounds, typically writing first checks of $1 million to $3 million, and is willing to lead. Beyond capital, a core part of its value proposition is strategic: it connects portfolio companies with UnityPoint's clinical and operational leaders to demo and validate solutions, and helps accelerate and scale them through prioritized IT access, expedited contracting, and marketing and earned-media support, all aligned with the health system's goals of lowering costs, improving quality of care and advancing population-health initiatives. The fund is led by Matthew Warrens, Managing Director of Innovation, and Austin Duke, Venture Investing Director. Its portfolio of around 17 companies, which has produced one IPO and three acquisitions, includes Health Catalyst, b.well Connected Health, whose $16 million Series A it led, OpenLoop Health, Carta Healthcare, HealthSnap and TailorMed, with its most recent disclosed deal being TailorMed's Series D in November 2024. By pairing capital with access to an integrated health system's clinical and operational network, UnityPoint Health Ventures backs the technologies improving care quality and lowering costs.